High Throughput Screening Identified a Substituted Imidazole as a Novel RANK Pathway-Selective Osteoclastogenesis Inhibitor-Reference-Cited by-同舟云学术

High Throughput Screening Identified a Substituted Imidazole as a Novel RANK Pathway-Selective Osteoclastogenesis Inhibitor

Author:

Chen Taosheng¹²,Knapp Anita C.³,Wu Yang¹,Huang Jinwen³,Lynch Jean S.³,Dickson John K.⁴,Lawrence R. Michael⁵,Feyen Jean H.M.³,Agler Michele L.¹

Affiliation:

1. Lead Discovery and Profiling, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, Wallingford, CT.

2. Present address: Department of Chemical Biology & Therapeutics, St. Jude Children’s Research Hospital, Memphis, TN.

3. Department of Metabolic and Cardiovascular Drug Discovery, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, Pennington, NJ.

4. Department of Discovery Chemistry, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, Pennington, NJ.

5. Department of Early Discovery Chemistry, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, Pennington, NJ.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Molecular Medicine

Link

Reference27 articles.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献